To investigate the safety and efficacy of three concentrations of DE-127 ophthalmic solution when compared to Placebo in subjects diagnosed with mild or moderate myopia. To investigate the dose response of DE-127.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
99
Low dose of DE-127 Ophthalmic Solution dosed once daily for 12 months
Medium dose of DE-127 Ophthalmic Solution dosed once daily for 12 months
High dose of DE-127 Ophthalmic Solution dosed once daily for 12 months
Singapore National Eye Centre
Singapore, Singapore
Spherical equivalent
Change from Baseline in spherical equivalent determined by cycloplegic autorefraction at Month 12 in the study eye.
Time frame: Month 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Placebo Ophthalmic Solution dosed once daily for 12 months